In the present study, the Oncomine and the Tumor Immune Assessment Resource (TIMER) databases were used to verify the expression level of RDM1 messenger RNA (mRNA) in different tumor tissues compared with normal control tissues. This evidence concerns the gene RDM1 and neoplasm.